MARIE ZAMBELLI: Open Payments
NPI 1508419656 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,567 in 46 payments from 17 companies in 2025. Trend: 2023 $20,367 · 2024 $3,349 · 2025 $1,567
Food & beverage: $1,567
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $684 |
| Saluda Medical Americas, Inc. | 1 | $191 |
| Boston Scientific Corporation | 4 | $153 |
| Abbott Laboratories | 3 | $145 |
| PFIZER INC. | 3 | $64 |
| Amgen Inc. | 3 | $57 |
| Astellas Pharma US Inc | 2 | $53 |
| Sumitomo Pharma America, Inc. | 2 | $48 |
| Medtronic, Inc. | 1 | $28 |
| Coastal Medical Technologies LLC | 1 | $26 |
Products named: QULIPTA, Evoke, UBRELVY, PROCLAIM, General - Pain Management, Veozah, GEMTESA, FREESTYLE LIBRE 3.
Industry payments across FL — which companies pay providers there.
